These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7328059)

  • 21. Effect of bestatin on syngeneic tumors in mice.
    Abe F; Shibuya K; Uchida M; Takahashi K; Horinishi H; Matsuda A; Ishizuka M; Takeuchi T; Umezawa H
    Gan; 1984 Jan; 75(1):89-94. PubMed ID: 6586596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of tunicamycin on anthracycline resistance in P388 murine leukemia cells.
    Chou TH; Kessel D
    Biochem Pharmacol; 1981 Nov; 30(22):3134-6. PubMed ID: 6950722
    [No Abstract]   [Full Text] [Related]  

  • 23. Synthesis and cytostatic activity of the antitumor antibiotic chartreusin derivatives.
    Kon K; Sugi H; Tamai K; Ueda Y; Yamada N
    J Antibiot (Tokyo); 1990 Apr; 43(4):372-82. PubMed ID: 2351612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Absence of antitumor activity of ORG 5895, a 11 beta-aziridinylmethyl derivative of estradiol, on the MXT mammary tumor and the P388 leukemia.
    Devleeschouwer N; Leclercq G; Danguy A; Atassi G
    Cancer Chemother Pharmacol; 1982; 8(3):315-6. PubMed ID: 7127663
    [No Abstract]   [Full Text] [Related]  

  • 25. Anthracycline resistance in P388 murine leukemia and its circumvention by calcium antagonists.
    Kessel D; Wilberding C
    Cancer Res; 1985 Apr; 45(4):1687-91. PubMed ID: 3919944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on a novel antitumor antibiotic, phenazinomycin: taxonomy, fermentation, isolation, and physicochemical and biological characteristics.
    Omura S; Eda S; Funayama S; Komiyama K; Takahashi Y; Woodruff HB
    J Antibiot (Tokyo); 1989 Jul; 42(7):1037-42. PubMed ID: 2753810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antitumor effect of dicyclohexylammonium sulfate, a potent inhibitor of spermidine synthase against P388 leukemia.
    Ito H; Hibasami H; Shimura K; Nagai J; Hidaka H
    Cancer Lett; 1982; 15(3):229-35. PubMed ID: 7116328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on high-dose chemotherapy of amygdalin in murine P388 lymphocytic leukaemia and P815 mast cell leukaemia.
    Chitnis MP; Adwankar MK; Amonkar AJ
    J Cancer Res Clin Oncol; 1985; 109(3):208-9. PubMed ID: 4008516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Sensitivity to chemotherapeutic preparations of anthracycline-resistant strains of murine leukemia P388].
    Demidova NS; Goncharova SA; Shiriaeva OA; Konovalova NP
    Eksp Onkol; 1989; 11(1):65-8. PubMed ID: 2924713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-salicylidene derivatives of pirarubicin.
    Ajito K; Ikeda D; Komuro K; Nosaka C; Wako N; Kondo S; Takeuchi T
    J Antibiot (Tokyo); 1989 Jul; 42(7):1133-44. PubMed ID: 2753818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Biological effect of bestatin against rat ascites hepatomas and enhancement of interferon production].
    Satoh H
    Jpn J Antibiot; 1984 Apr; 37(4):593-6. PubMed ID: 6206251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Schedule-dependent variations in the response of murine P388 leukemia to cyclophosphamide in combination with interferons-alpha/beta.
    Borden EC; Sidky YA; Hatcher JF; Bryan GT
    Cancer Res; 1988 May; 48(9):2329-34. PubMed ID: 3356000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo response of mitoxantrone and doxorubicin with dipyrone in parental and doxorubicin-resistant P388 leukemia.
    Kamath NS; Chitnis MP
    Oncology; 1990; 47(2):166-9. PubMed ID: 2314829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined effects of bromovinyldeoxyuridine and fractionated or continuous administration of 5-fluorouracil in P388 leukemia-bearing mice.
    Keizer HJ; Pauwels R; Landuyt W; Balzarini J; van der Schueren E; De Clercq E
    Cancer Lett; 1988 Mar; 39(2):217-23. PubMed ID: 3359416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival responses to new cytostatic hexitols of P388 mouse and K562 human leukemia cells in vitro.
    Pályi I
    Cancer Treat Rep; 1986 Feb; 70(2):279-84. PubMed ID: 3948192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The effect of finoptin on doxorubicin accumulation in leukemia P-388 cells with induced resistance to the combination of finoptin and doxorubicin].
    Moroz LV; Donenko FV; Borovkova NB; Sitdikova SM; Kabieva AO
    Biull Eksp Biol Med; 1990 Mar; 109(3):290-2. PubMed ID: 2364157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytotoxicity of bacteriohopane-32-ol against mouse leukemia L1210 and P388 cells in vitro.
    Nagumo A; Takanashi K; Hojo H; Suzuki Y
    Toxicol Lett; 1991 Nov; 58(3):309-13. PubMed ID: 1957326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensitivity to anthracyclines in P388/dx leukaemia cells.
    Bossa R; Dasdia T; Galatulas I; Zunino F
    Anticancer Res; 1986; 6(5):1037-9. PubMed ID: 3099628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antitumor activity of a novel antitumor antibiotic, quinocarmycin citrate (KW2152).
    Fujimoto K; Oka T; Morimoto M
    Cancer Res; 1987 Mar; 47(6):1516-22. PubMed ID: 2434218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overcoming drug resistance in cancer cells with synthetic isoprenoids.
    Yamaguchi T; Nakagawa M; Shiraishi N; Yoshida T; Kiyosue T; Arita M; Akiyama S; Kuwano M
    J Natl Cancer Inst; 1986 May; 76(5):947-53. PubMed ID: 3457980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.